Resveratrol and non-ethanolic components of wine in experimental cardiology

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 13, Issue 2, 2003, Pages 100-103

  De Lorgeril, M ^a,b   Salen, P ^a   Guiraud, A ^a   Boucher, F ^a   De Leiris, J ^a  

^a UNIV GRENOBLE ALPES   (France)

^b UFR de Medecine et Pharmacie   (France)

Author keywords

Ethanol; Experimental cardiology; Non ethanolic components of wine; Resveratrol

Indexed keywords

RESVERATROL; ANTIOXIDANT; STILBENE DERIVATIVE;

ALCOHOL CONSUMPTION; CHEMOPROPHYLAXIS; DISEASE SEVERITY; GRAPE JUICE; HEART FUNCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART VENTRICLE ARRHYTHMIA; HUMAN; REPERFUSION INJURY; REVIEW; ANIMAL; ARTICLE; CARDIOVASCULAR DISEASE; WINE;

ANIMALIA;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; HUMANS; STILBENES; WINE;

EID: 0642307078     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(03)80025-X     Document Type: Note

References (35)

1. Pearson TA (1996) Alcohol and heart disease. Circulation 94: 3023-3025
2. Rimm EB, Giovannucci EL, Willett WC, et al (1991) Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 338: 464-468
3. Stampfer MJ, Colditz GA, Willett WC, et al (1988) A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 319: 267-273
4. Camargo CA, Hennekens CH, Gaziano JM, et al (1997) Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med 157: 79-85
5. Di Castelnuovo A, Rotondo S, Iacoviello L, et al (2002) Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 105: 2836-2844
6. Gronbaek M, Deis A, Sorensen T, et al (1995) Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 310: 1165-1169.
7. Gaziano JM, Gaziano TA, Glynn RJ, et al (2000) Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol 35: 96-105.
8. Thun MJ, Peto R, Lopez AD, et al (1997) Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med 337: 1705-1714
9. Rimm EB, Fosher K, Criqui M, et al (1999) Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319: 1523-1528
10. Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets aggregation and the French Paradox for coronary heart disease. Lancet 339: 1523-1526
11. de Lorgeril M, Salen P (1999) Wine ethanol, platelets, and Mediterranean diet. Lancet 353: 1067
12. Muntwyler J, Hennekens CH, Buring JE, et al (1998) Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet 352: 1882-1885
13. Mukamal KJ, Maclure M, Muller JE, et al (2001) Prior alcohol consumption and mortality following acute myocardial infarction. JAMA 285: 1965-1970
14. de Lorgeril M, Salen P, Martin JL, et al (2002) Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation 106: 1465-1469
15. Albert CM, Manson JE, Cook NR et al (1999) Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation 100: 944-950
16. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136
17. Miyamae M, Diamond I, Weiner MW, et al (1997) Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci USA 94: 3235-3239
18. Zhou HZ, Karliner JS, Gray MO (2002) Moderate alcohol consumption induces sustained cardiac protection by activating PKC-epsilon and Akt. AJP- Heart and Circulatory Physiology 283: H165-H174
19. Chen CH, Gray MO, Mochly-Rosen D (1999) Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: role of epsilon protein kinase C. Proc Natl Acad Sci USA 96: 12784-12789
20. ATPchannel mediate the beneficial effects of chronic ethanol ingestion. AJP-Heart and Circulatory Physiology 279: H2574-H2579
21. Krenz M, Baines CP, Yang XM, et al (2001) Acute ethanol exposure fails to elicit preconditioning in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol 37: 601-607
22. Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22: 19-34
23. Pataki T, Bak I, Kovacs P, et al (2002) Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am J Clin Nutr 75: 894-899
24. Hattori R, Otani H, Maulik N, Das D (2002) Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol 282: H1988-H1995
25. Imamura G, Bertelli A, Bertelli A, et al (2002) Pharmacological preconditioniong with resveratrol: an insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 282: H1996-H2003
26. Wallerath T, Deckert G, Ternes T, et al (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106: 1652-1658
27. Bertelli AA, Giovannini L, Stradi R, et al (1998) Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp Clin Res 24: 51-55
28. Savouret JF, Berdeaux A, Casper RF (2003) The aryl hydrocarbon receptor and its xenobiotic ligands: a fundamental trigger for cardiovascular diseases. Nutr Metab Cardiovasc Dis 13: 104-113
29. Heid SE, Walker MK, Swanson HI (2001) Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol Sci 61: 187-196
30. Walker MK, Catron TF (2000) Characterisation of cardiotoxicity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related chemicals during early chick embryo development. Toxicol Appl Pharmacol 167: 210-221
31. de Lorgeril M, Salen P, Laporte F, et al (2001) Potential use of nuts for the prevention and treatment of coronary heart disease: from natural to functional foods. Nutr Metab Cardiovasc Dis 11: 362-371
32. Jang M, Cai L, Udeani GO, et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220
33. Bhat KP, Lantvit D, Christov K, et al. (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 61: 7456-7463
34. Moreno JJ (2000) Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. J Pharmacol Exp Ther 294: 333-338
35. de Lorgeril M, Salen P, Paillard F, et al (2002) Mediterranean diet and the French paradox: two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease. Cardiovasc Res 54: 503-515